Devos, T., Geukens, T., Schauvlieghe, A., Ariën, K. K., Barbezange, C., Cleeren, M., . . . Meyfroidt, G. (2020). A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: The Donated Antibodies Working against nCoV (DAWn-Plasma) trial. Trials.
शिकागो स्टाइल उद्धरणDevos, Timothy, et al. "A Randomized, Multicentre, Open-label Phase II Proof-of-concept Trial Investigating the Clinical Efficacy and Safety of the Addition of Convalescent Plasma to the Standard of Care in Patients Hospitalized With COVID-19: The Donated Antibodies Working against NCoV (DAWn-Plasma) Trial." Trials 2020.
एमएलए उद्धरणDevos, Timothy, et al. "A Randomized, Multicentre, Open-label Phase II Proof-of-concept Trial Investigating the Clinical Efficacy and Safety of the Addition of Convalescent Plasma to the Standard of Care in Patients Hospitalized With COVID-19: The Donated Antibodies Working against NCoV (DAWn-Plasma) Trial." Trials 2020.